TerminatedNot Applicable

Cerebral Autoregulation and COVID-19

Stopped: Low rate of enrollment

Greece7 participantsStarted 2021-06-22

Plain-language summary

This study aims to assess cerebral autoregulation by near-infrared spectroscopy (NIRS) in patients with severe coronavirus disease 19 (COVID-19). Results on COVID-19 participants will be compared with prior results of patients with septic shock and cardiac arrest, who participated in NCT03649633 and NCT02790788, respectively.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Admission to ICU and endotracheal intubation/mechanical ventilation for severe COVID-19 infection Exclusion Criteria: * Age \<18 years * Pregnancy * Patients with a terminal underlying disease who are unlikely to survive until discharge from the hospital * Patients with acquired immunodeficiency and ("pre-COVID") lymphocyte Cluster Differentiation 4+ count \<50 / μL * Patients with COVID-19 who have been transferred from another hospital * Patients with a history of allergic reaction * Use of prone position to facilitate mechanical ventilation * Absence of signed informed consent from a first degree relative

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Cerebral autoregulation

Timeframe: Days 1-4 of ICU admission

Cerebral blood flow

Timeframe: Days 1-4 of ICU admission

Trial details

NCT IDNCT04930874

SponsorUniversity of Athens

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-09-16

View on ClinicalTrials.gov More COVID-19 Acute Respiratory Distress Syndrome trials